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Background: Surgery is the primary treatment for colorectal cancer for both curative and palliative intent.
Availability of high quality surgery data is essential for assessing many aspects of the quality of colorectal cancer
care. The objective of this study was to determine the quality of different administrative data sources in identifying
surgery for colorectal cancer with respect to completeness and accuracy.
Methods: All residents in Alberta, Canada who were diagnosed with invasive colorectal cancer in years 2000-2005
were identified from the Alberta Cancer Registry and included in the study. Surgery data for these patients were
obtained from the Cancer Registry (which collects the date of surgery for which the primary tumor was removed)
and compared to surgery data obtained from two different administrative data sources: Physician Billing and
Hospital Inpatient data. Sensitivity, specificity, positive predictive value, negative predictive value and observed
agreement were calculated compared to the Cancer Registry data.
Results: The Physician Billing data alone or combined with Hospital Inpatient data demonstrated equally high
sensitivity (97% for both) and observed agreement with the Cancer Registry data (93% for both) for identifying
surgeries. The Hospital Inpatient data, however, had the highest specificity (80%). The positive predictive value
varied by disease stage and across data sources for stage IV (99% for stages I-III and 83-89% for stage IV), the
specificity is better for colon cancer surgeries (72-85%) than for rectal cancer surgeries (60-73%); validation measures
did not vary over time.
Conclusion: Physician Billing data identify the colorectal cancer surgery more completely than Hospital Inpatient
data although both sources have a high level of completeness.
Keywords: Colorectal cancer, Surgery, Data validation, Administrative data, Sensitivity, Specificity, Positive predictive
value, Negative predictive valueBackground
Surgical resection is the primary treatment for colorectal
cancer, resulting in cure in 80% of patients [1-4]. Even if
cure is not possible, palliative surgery may be needed to
control symptoms such as pain, bleeding, obstruction or
perforation [3,4]. Maintaining high quality surgery data
is, therefore, essential to measuring many aspects of the
quality of colorectal cancer care including adherence to* Correspondence: marcy.winget@albertahealthservices.ca
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A well-established cancer registry in many countries
provides the primary data source used for identifying
cancer diagnosis and sometimes treatment. When cancer
registries do collect treatment information, it has been
shown to have high quality [5] and such registries are
central in enabling assessment of the quality of cancer
care [6,7]. Each registry, however, is managed to meet
the expectations for its primary role [7]. In many
instances, the primary role of a cancer registry is only to
monitor cancer incidence and death for surveillance pur-
poses. Treatment data are, therefore, not routinely col-
lected by all cancer registries, nor, when collected, are
they collected in the same way. For instance, somehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tion, others collect only the surgery to remove the pri-
mary tumor and others collect all surgeries related to
the cancer.
Variation in data collection patterns of cancer treat-
ment by cancer registries makes it challenging to con-
duct comparison studies across jurisdictions related to
treatment patterns, adherence to treatment guidelines,
or similar studies. Such studies are important for under-
standing variation in cancer survival and cancer preva-
lence across jurisdictions and may help inform ideas for
implementing changes in cancer care service delivery.
In the absence of standardized collection and coding
of treatment data by a cancer registry or other data
source, administrative data are the most available data
sources for basic information related to receipt of treat-
ment, particularly hospital-based treatment [8,9]. Be-
cause administrative data are not developed for research
or quality assessment purposes, it is imperative to be
aware of the strengths and weaknesses of the data prior
to using them in order to avoid making and disseminat-
ing misleading or inaccurate information [10]. Data val-
idation is a critical step towards understanding potential
biases that may be created by using such data. The pur-
pose of this study, therefore, was to evaluate the com-
pleteness of different administrative data sources in
identifying surgery for colorectal cancer compared to a
cancer registry that collects the date of surgery con-
ducted for removal of the primary tumor.
Methods
Inclusion and exclusion criteria
All residents of Alberta, Canada who were diagnosed with
invasive colon (International Classification of Diseases for
Oncology (ICD-O) [11] codes: c18.0, c18.2-c18.9) or rectal
(ICD-O c19.9 and c20.9) cancer in 2000-2005 were identi-
fied from the Alberta Cancer Registry and included in the
study. Patients were excluded if they had stage 0 cancer, a
histology that is not staged according to the Collaborative
Staging Guidelines for colorectal cancer (for example, sar-
comas) [12], or missing the unique life time identifier
(ULI) needed to link the data across the multiple data
sources. The ULI is a code that uniquely identifies indivi-
duals enrolled in the Alberta Health Care Insurance Plan,
the universal healthcare insurance provider for all resi-
dents of Alberta, Canada. Once assigned, an individual’s
code does not change even if s/he moves in and out of the
province. Patients for whom their disease stage was miss-
ing for reasons other than having a histology that could
not be staged were included.
Data from the Alberta cancer registry
Diagnosis and surgery dates were obtained from the
Alberta Cancer Registry. In addition to its legislativemandate to register and code all cancer diagnoses in the
province, the Alberta Cancer Registry also collects and
maintains demographic and clinical information, includ-
ing all treatment modalities for the initial diagnosis and
start dates of each modality. The date of surgery
recorded in the cancer registry is the date of removal of
the primary tumor based on pathology and surgical
reports and does not include surgery to metastatic sites;
only one surgery date per cancer diagnosis is recorded.
All labs, hospitals and clinicians are required by law to
report all cancer cases and furnish any additional infor-
mation requested by the Alberta Cancer Registry. The
Alberta Cancer Registry is reviewed annually by the
North American Association of Comprehensive Cancer
Registries (NAACCR) to ascertain the quality and com-
pleteness of its data and is regularly awarded the highest
level of certification [13].Administrative data sources
Colorectal surgery data were obtained from two provin-
cial administrative databases: 1) the Discharge Abstract
Database (Hospital Inpatient data) which records diag-
nosis and procedures on all admissions to hospitals in
Alberta; and 2) the Physician Billing database, which
contains all billing claims submitted by physicians
remunerated on a fee-for-service basis. From each of
these databases, dates and codes for the first colorectal
surgery were identified and included that occurred 7
days prior to or up to 548 days (1.5 years) after the diag-
nosis date. The lower bound of the window was to ad-
dress potential inaccuracy of dates in the Physician
Billing data and the upper bound was based on the max-
imum time from diagnosis to surgery that was observed
in the Cancer Registry surgery dates. The date of the
first colorectal cancer surgery within the time window
was identified from each data source and included in
the study. In practice, if more than one surgery is con-
ducted related to colorectal cancer, the first is expected
to be for the removal of the primary tumor as subse-
quent surgeries are generally for rectal reconstruction,
stoma removal, or similar; thus the first surgery is
expected to be the same as the surgery recorded in the
Cancer Registry.
The Physician Billing and Hospital Inpatient data were
selected for the study because: 1) almost all surgeons are
paid fee-for-service, therefore Physician Billing should
capture surgeries well and 2) colorectal surgery can only
be conducted on an inpatient basis, therefore, the Hos-
pital Inpatient database should also be fairly complete.
Additionally, trained and certified Health Records Tech-
nicians are responsible for coding diagnoses and pro-
cedures that are entered into the Hospital Inpatient
database so information should be accurate.
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change in the coding schema used for coding procedures
in the Hospital Inpatient data in April 2002 and we
wanted to assess whether these changes would impact
the data validity. Physician billing uses Canadian Classifi-
cation of Procedures (CCP) coding system; Hospital In-
patient prior to April 2002 used the ICD-9-Clinical
Modification (CM) coding system and switched to Can-
adian Classification of Health Interventions (CCI) coding
system in April 2002. Colorectal surgery codes were
identified for each data source and coding system with
input from local physicians and a literature search to en-
sure all appropriate codes were included. The complete
list of the colorectal surgery codes included is in Add-
itional file 1.
A dataset was also created that combined the two ad-
ministrative datasets to determine if combining surgery
information enhanced the completeness and validity of
the data over either of the single administrative data
sources. Data were combined using the following rules:
1) if a surgery date for a patient was only in one of the
data sources then that date was included in the com-
bined dataset; 2) if the data sources had two different
surgery dates, the earlier date was included in the com-
bined dataset.
The databases used in the study are not publicly avail-
able. The Alberta Cancer Registry data were made avail-
able upon ethics approval. The provincial administrative
databases are governed by the provincial ministry, Al-
berta Health and Wellness (AHW). AHW provided the
provincial administrative data required for the study
after conducting a Privacy Impact Assessment and sign-
ing a confidentiality agreement. Ethics approval for the
study was obtained from the Alberta Cancer Research
Ethics Board.
Data analysis
The date of surgery in the Alberta Cancer Registry
was considered to be the source of truth. Sensitivity,
specificity, positive predictive value (PPV) and negative
predictive value (NPV) were calculated for the Physician
Billing data, the Hospital Inpatient data, and the com-
bined administrative dataset. The above measures were
calculated overall and by year of diagnosis, stage at
diagnosis, and tumor site; these factors were chosen
because they were considered to be the factors by which
there would most likely be variation in completeness of
the administrative data. The observed agreement was
calculated to test the strength of agreement instead
of the Kappa statistic because the latter is influenced
substantially by trait prevalence and imbalanced mar-
ginal distributions [14-18]. In our context, this is par-
ticularly relevant in the analysis by stage as more than
98% of patients with stages I-III disease received surgery.Although there are not set standards for defining excel-
lent, good, acceptable, and poor related to observed
agreement, it is reasonable to define “excellent” as 90-
100% and “good” as 80-89%. The 95% confidence inter-
val for each estimate was calculated. Unstable estimates,
defined as having a 95% confidence interval wider than
15% or a width that was 40% or more than the estimate,
are noted in the tables. In order to allow ease of com-
parison of validation measures across datasets in the
main tables, confidence intervals are presented in Add-
itional file 2: Appendices B-D only. All analyses were
performed using statistical software SAS 9.1.3 (SAS In-
stitute, Cary, NC, USA) or STATA/SE 10.0 (StataCorp
LP, TX, USA).
Results
A total of 8,533 patients residing in Alberta were diag-
nosed with invasive colorectal cancer in years 2000-2005
. There were 225 patients excluded from the study for
the following reasons: 2 were missing their ULI; 140 had
a cancer histology that cannot be staged using Collab-
orative Staging rules for colorectal cancer; and 83
patients had a stage 0 cancer. The remaining 8,308 colo-
rectal cancer patients were included in the study.
Table 1 compares the number and percentage of
patients who had surgery according to each of the Al-
berta Cancer Registry, Physician Billing, Hospital In-
patient data, and the combined administrative dataset.
There were 7,066 (85%) patients who had surgery
according to the Alberta Cancer Registry out of 8,308
colorectal cancer patients diagnosed in years 2000-2005.
Both administrative datasets alone or combined identi-
fied similar numbers and percentages of patients who
had surgery as the Cancer Registry for all years com-
bined and by year of diagnosis, although the number
identified in the Physician Billing was slightly higher
than other data sources in all diagnosis years. The great-
est differences between data sources were for patients
diagnosed with stage I disease and with stage IV disease.
In the case of stage I patients, the cancer registry
recorded more surgeries than the administrative data
sources (99% of patients vs. 87-91%, respectively). Con-
versely, the Cancer Registry identified fewer patients
who had surgery with stage IV disease than the adminis-
trative datasets (60% vs. 66-74%, respectively).
Table 2 summarizes the validation measures for the
administrative data sources compared to the Cancer
Registry overall and by year, stage and tumor site. The
validation measures and their corresponding confidence
intervals are shown in Additional file 1. The Physician
Billing data alone and combined with Hospital Inpatient
data have similar high sensitivity (97%) and PPV (95%).
Conversely, the Hospital Inpatient data has higher
specificity than the Physician Billing, 80% vs. 72%,
Table 1 Colorectal surgery patients identified by data source of cancer registry, physician billing and hospital
inpatient data
Surgery Patients Identified from Each Data Source
Factors All
Patients
Cancer Registry Physician Billing Hospital Inpatient Combined Administrative
n n (%)1 n (%)1 n (%)1 n (%)1
8308 7066 (85) 7173 (86) 6905 (83) 7241 (87)
Year
2000 1324 1149 (87) 1168 (88) 1131 (85) 1183 (89)
2001 1331 1126 (85) 1155 (87) 1109 (83) 1166 (88)
2002 1337 1152 (86) 1170 (88) 1135 (85) 1181 (88)
2003 1432 1231 (86) 1232 (86) 1200 (84) 1250 (87)
2004 1418 1176 (83) 1202 (85) 1152 (81) 1210 (85)
2005 1466 1232 (84) 1246 (85) 1194 (81) 1257 (86)
Stage
I 1387 1379 (99) 1251 (90) 1204 (87) 1259 (91)
II 2207 2166 (98) 2167 (98) 2125 (96) 2174 (99)
III 1902 1875 (99) 1867 (98) 1835 (96) 1870 (98)
IV 1953 1164 (60) 1396 (71) 1293 (66) 1436 (74)
Missing 859 482 (56) 492 (57) 464 (54) 508 (59)
Tumor Site
Colon 5303 4534 (85) 4585 (86) 4429 (84) 4608 (87)
Rectum 3005 2532 (84) 2588 (86) 2492 (83) 2639 (88)
1 Percent is based on “All Patients” in each row.
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registry is over 90% for all the administrative datasets
except for patients diagnosed with stage IV or unknown
stage disease, where it is 84-89% depending on the stage
and dataset. Similarly, the PPV is 99% for disease stages
I-III in all datasets but lower for patients diagnosed at
stage IV or unknown stage (range 80-89%). Estimates for
specificity and NPV are unstable for stage I-III patients
in all data sources, because of the very small number of
patients who did not have surgery in all the data sources.
There is a common trend across the data sources that
all measures for rectal cancer are lower than for colon
cancer.
To examine the accuracy of surgery dates identified
from administrative data sources, the date of surgery
based on the Cancer Registry was subtracted from the
date of surgery based on each of the administrative data-
sets. Over 90% of the surgery dates in both the individ-
ual and combined administrative datasets matched the
dates in the Cancer Registry exactly (not shown in the
tables). This confirms that the accuracy of dates in all
the data sources, even Physician Billing, is quite good.
It also confirms the assumption that the first surgery
in any of the administrative data sources corresponds
to the surgery recorded in the Cancer Registry, that is,
removal of the primary tumor, was correct.Discussion
The aim of the study was to assess two different admin-
istrative data sources with respect to completeness and
accuracy of colorectal cancer surgery data compared to
a cancer registry that collects only the date of the sur-
gery responsible for removal of the primary tumor. The
findings of the study support the validity and compar-
ability of colorectal surgery data from administrative
data sources for this purpose. Specifically, Physician Bill-
ing data alone or combined with Hospital Inpatient data,
are the most comparable alternative data sources to a
cancer registry for identifying the date of the surgery in
which the primary colorectal tumor was removed.
The largest discrepancy between the cancer registry
surgery data and the administrative data sources oc-
curred for patients with stage I and stage IV disease.
Specifically, proportionally more surgeries for stage I
cancer patients were identified in the cancer registry
than either of the administrative data sources and, con-
versely, fewer were found in the cancer registry for stage
IV patients than in the administrative data sources; this
is likely due to rules used by the Alberta Cancer Registry
in defining surgery. The cancer registry defines surgery
as the event that results in excision of the primary
tumor. A polypectomy in a stage I patient, therefore,
may be coded as a surgery in the Alberta Cancer
Table 2 Validation measures1 for colorectal surgery in physician billing and hospital inpatient data compared to the
Alberta Cancer Registry overall and by year of diagnosis, stage and tumor site
Physician Billing Data Hospital Inpatient Data Combined Administrative Data
Observed Observed Observed
Factors Sens. Spec. PPV NPV Agreement Sens. Spec. PPV NPV Agreement Sens. Spec. PPV NPV Agreement
% % % % % % % % % % % % % % %
All 97 72 95 79 93 94 80 96 72 92 97 68 95 79 93
Year
2000 97 692 95 772 93 96 832 97 752 94 97 642 95 792 93
2001 97 672 94 782 92 95 802 96 742 93 97 622 93 772 91
2002 97 702 95 772 93 95 772 96 702 92 97 652 95 782 92
2003 97 802 97 802 94 94 812 97 702 92 97 742 96 812 94
2004 97 742 95 832 93 94 832 96 762 92 97 722 94 842 93
2005 96 742 95 782 92 93 792 96 682 91 96 692 94 772 92
Stage
I 91 883 100 53 91 87 883 100 43 87 91 883 100 53 91
II 99 493 99 503 98 97 633 99 323 97 99 413 99 523 98
III 99 703 99 543 99 98 783 100 313 97 99 703 100 593 99
IV 99 692 82 98 87 97 79 87 94 89 99 642 80 98 85
Missing 88 822 862 842 85 852 862 89 822 85 88 782 842 842 84
Tumor Site
Colon 97 752 96 80 94 95 85 97 75 94 97 732 95 80 93
Rectal 96 692 94 782 92 93 732 95 672 90 97 602 93 782 91
1 The width of the 95% confidence interval for estimates without a superscript are< 6%.
2 Width of the 95% confidence interval is 6 – 14%.
3 Unstable estimate: width of 95% confidence interval is >14% and/or the width of the interval is >40% of the value of the estimate.
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required to ensure negative margins. It may be possible
to create an algorithm using administrative data that
mimics more closely the rules of the cancer registry for
stage I patients who receive polypectomy rather than an
inpatient surgery; the current study, however, was fo-
cused on the comparability of the data sources specific-
ally using surgery codes from the administrative data
sources.
With respect to stage IV patients, again, the Alberta
Cancer Registry only captures the surgery responsible
for removal of the primary tumor. Some surgeries on
patients with stage IV colorectal cancer are de-bulking
as opposed to removing the majority of the tumor. Some
may be done only to create a stoma or re-route the
colon. It is expected that all of these surgeries will be
identified in the administrative data sources but not in a
registry that captures only removal of the primary
tumor. A clear interpretation of results must be based
on fully understanding of coding rules and limitation of
each data source.
In addition to disease stage, consistency of the valid-
ation measures over time was evaluated. None of the
validation measures varied over time for any of the datasources indicating the reliability of the administrative
data sources, even over a time period in which coding
systems changed. Changes made to reimbursement pol-
icies for colorectal surgeries in future years, however,
could impact the generalizability of this conclusion, so
need to be considered. The fact that there were not
changes in the values of the validation measures for the
Hospital Inpatient data, even though there was a change
in coding from ICD-9-CM to CCI codes over the study
period, is a reflection of the robustness of the coding
systems for colorectal surgery and also of the quality and
consistency of the training received by health records
technicians responsible for coding the hospital data.
The results of our study suggest that individual Phys-
ician Billing data can identify 1% more surgeries or 2%
more if combined with Hospital Inpatient data com-
pared to the surgery records identified from Cancer
Registry. Depending on the circumstances, this small dif-
ference may or may not matter for addressing a research
or quality question. The high level of completeness and
accuracy in Physician Billing data alone and in combin-
ation with Hospital Inpatient data indicates that admin-
istrative data can serve as excellent sources to identify
cancer surgeries. The findings are consistent with other
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completeness and validity of administrative data sources
for identifying breast cancer surgery [8,19-21]. The find-
ings of this study are likely generalizable to other juris-
dictions which have universal health insurance and/or
for which surgeons are remunerated primarily on a fee-
for-service basis and for similar procedures that are per-
formed primarily or only in a hospital.
In addition to cross-jurisdiction comparisons, another
potentially important application of administrative data
as the source for cancer surgery data compared to a data
source such as a cancer registry, is the relative quick
availability of the data. It takes the Alberta Cancer Regis-
try 18 months to 2 years to complete the annual coding
of all cancer cases including treatment information; this
time period is probably typical of other registries that
belong to NAACCR given the organization’s reporting
period requirements. Hospital Inpatient data and phys-
ician billing data, however, are generally available in
much closer proximity to the date a treatment such as
surgery occurs, approximately three to six months. Phys-
ician billing and Hospital Inpatient data can, therefore,
be used for monitoring high level quality measures,
measuring the impact of certain types of changes to the
health care system, and facilitating informed responsive-
ness to issues within the health care system as they arise.
In spite of these strengths, an important limitation, how-
ever is that administrative data by themselves cannot be
used to address questions that require information
related to clinical case mix of patients.Conclusions
In conclusion, both Physician Billing and Hospital In-
patient data are valid sources for identifying the date of
the surgery responsible for removing the primary colo-
rectal cancer. Accuracy of the physician billing data,
however, is subject to the fee code policy. Caution is
needed in the conduct and interpretation of studies
based on physician billing data; strong understanding of
the way in which physicians use billing codes and the
percentage of physicians who perform the procedure of
interest that bill for it is needed. Validation of the data is
also critical.Additional files
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